2020
DOI: 10.3389/fnins.2020.00267
|View full text |Cite
|
Sign up to set email alerts
|

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
228
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 361 publications
(256 citation statements)
references
References 178 publications
2
228
0
Order By: Relevance
“…GPX4, so when it was replaced by sulfur in GPX4, GPX4 fails in the activity of resisting overoxidation and inhibiting ferroptosis (Ingold et al, 2018;Song and Long, 2020).…”
Section: Gpx4 and Gsh In Ferroptosismentioning
confidence: 99%
“…GPX4, so when it was replaced by sulfur in GPX4, GPX4 fails in the activity of resisting overoxidation and inhibiting ferroptosis (Ingold et al, 2018;Song and Long, 2020).…”
Section: Gpx4 and Gsh In Ferroptosismentioning
confidence: 99%
“…It is important to note that several of these inductions are part of the known antioxidant ferroptosis-mitigating response under the control of the transcription factor NRF2 (encoded by the Nfe2l2 gene), with experimental confirmation for FTL1 / FTH1 / HMOX1 / NQO1 [66,67]. According to GeneCards database (accessed on 31 July 2020), the NRF2 binding site exists also in the promoter of genes coding for CYB5A / CISD2 / MCEE / CREG1 / TRAF2 / ACYP1 / NSMCE2 / MAP1LC3A / GPR126 / PTGES / TRAF2 / SERPINE2, whereas STEAP4 / JMJD6 / ARMC1 / GPSM2 / MSRA promoters contain only the ARNT binding site needed by the transcription factor HIF1A to control hypoxia responses.…”
Section: Preprintsmentioning
confidence: 99%
“…It is important to note that several of these inductions are part of the known antioxidant ferroptosis-mitigating response under the control of the transcription factor NRF2 (Nuclear factor, erythroid 2 like 2, encoded by the Nfe2l2 gene), with experimental confirmation for FTL1/FTH1/HMOX1/NQO1 [NAD(P)H quinone dehydrogenase 1] [ 60 , 61 ]. According to GeneCards database (accessed on 31 July 2020), the NRF2 binding site exists also in the promoter of genes coding for CYB5A (Cytochrome B5 type A)/CISD2/MCEE (Methylmalonyl-CoA Epimerase)/CREG1 (Cellular repressor of E1A stimulated genes 1)/TRAF2 (TNF receptor-associated factor 2)/ACYP1 (Acylphosophatase 1)/NSMCE2 (Non-structural maintenance of chromosomes element 2 homolog)/MAP1LC3A (Microtubule-associated protein 1 light chain 3 alpha)/GPR126 (G-protein coupled receptor 126)/PTGES (Prostaglandin E synthase)/SERPINE2 (Serpin family E member 2), whereas STEAP4 (Six transmembrane epithelial antigen of the prostate)/JMJD6 (Jumonji domain protein 6)/ARMC1 (Armadillo repeat containing 1)/GPSM2 (G Protein signaling modulator 2)/MSRA (Methionine sulfoxide reductase A) promoters contain only the ARNT binding site (Aryl hydrocarbon receptor nuclear translocator) needed by the transcription factor HIF1A (Hypoxia-Inducible Factor 1-alpha) to control hypoxia responses.…”
Section: Resultsmentioning
confidence: 99%